Yahoo Finance • 2 months ago
Investing.com - Volitionrx Ltd (NYSE: VNRX) reported second quarter EPS of $-0.060, $0.01 worse than the analyst estimate of $-0.047. Revenue for the quarter came in at $406.69K versus the consensus estimate of $537.62K. Volitionrx Ltd’... Full story
Yahoo Finance • 2 months ago
* VolitionRX press release [https://seekingalpha.com/pr/20201938-volitionrx-limited-announces-second-quarter-2025-financial-results-and-business-update] (NYSE:VNRX [https://seekingalpha.com/symbol/VNRX]): Q2 Recorded just over $0.4 milli... Full story
Yahoo Finance • 3 months ago
* VolitionRx (NYSE:VNRX [https://seekingalpha.com/symbol/VNRX]) filed a prospectus to sale 23.44 million shares of common stock. * The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder.... Full story
Yahoo Finance • 2 years ago
LAS VEGAS, NV / ACCESSWIRE / April 24, 2023 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 25-27, 2023, where 77 MicroCap public and private companies will be presenting at the Horseshoe Hotel & Casino... Full story
Yahoo Finance • 3 years ago
HENDERSON, Nev., July 29, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today the pricing of its underwritten public offering of 3,000,000 shares of its common s... Full story
Yahoo Finance • 3 years ago
NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its quarterly Emerging Growth Invitational investor conference on June 23, 2022. The... Full story
Yahoo Finance • 3 years ago
NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its quarterly Emerging Growth Invitational investor conference on June 23, 2022. The... Full story